Image: Profile picture of Cathrine Rein Carlson

Cathrine Rein Carlson

Group Leader & Senior Researcher

Carlson group

Email: cathrine.carlson@medisin.uio.no
Phone: +47 230 16842

Cathrine Rein Carlson joined IEMR in 2006. She has a broad background in biochemistry, molecular biology and signal transduction. She received Master’s degree from the Norwegian University of Science and Technology (NTNU) in 1989, and obtained a PhD at University of Oslo (UiO) in 1994.

She has previously been employed at the Biotechnology Centre of Oslo, The Norwegian Radium Hospital, and Oregon Health & Sciences University, USA.

List all publications with affiliations:

– Biotechnology Centre of Oslo and Institute of Pharmacy, University of Oslo
– Department of Biophysics and Cell Biology, Institute for Cancer Research, University of Oslo
– Department of Medical Biochemistry, Institute for Basic Medical Sciences, University of Oslo
– Department of Microbiology, Biotechnology Center of Oslo, University of Oslo
– Institute for Experimental Medical Research and Oslo University Hospital, University of Oslo
– Institute of Medical Biochemistry, University of Oslo
– Institute of Pharmacy and Biotechnology Centre of Oslo, University of Oslo

Research area

  • Molecular Cardiology

Latest publications

view all >
Lunde IG, Aronsen JM, Melleby AO, Strand ME, Skogestad J, Bendiksen BA, Ahmed MS, Sjaastad I, Attramadal H, Carlson CR, Christensen G (2022)
Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy
Mol Biol Rep
PubMed 36205855 DOI 10.1007/s11033-022-07985-y
Støle TP, Lunde M, Shen X, Martinsen M, Lunde PK, Li J, Lockwood F, Sjaastad I, Louch WE, Aronsen JM, Christensen G, Carlson CR (2022)
The female syndecan-4-/- heart has smaller cardiomyocytes, augmented insulin/pSer473-Akt/pSer9-GSK-3β signaling, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels
Front Cell Dev Biol, 10, 908126
PubMed 36092718 DOI 10.3389/fcell.2022.908126
Carlson CR, Aronsen JM, Bergan-Dahl A, Moutty MC, Lunde M, Lunde PK, Jarstadmarken H, Wanichawan P, Pereira L, Kolstad TRS, Dalhus B, Subramanian H, Hille S, Christensen G, Müller OJ, Nikolaev V, Bers DM, Sjaastad I, Shen X, Louch WE, Klussmann E, Sejersted OM (2021)
AKAP18δ Anchors and Regulates CaMKII Activity at Phospholamban-SERCA2 and RYR
Circ Res, 130 (1), 27-44
PubMed 34814703 DOI 10.1161/CIRCRESAHA.120.317976
Wanichawan P, Skogestad J, Lunde M, Støle TP, Stensland M, Nyman TA, Sjaastad I, Sejersted OM, Aronsen JM, Carlson CR (2021)
Design of a Proteolytically Stable Sodium-Calcium Exchanger 1 Activator Peptide for In Vivo Studies
Front Pharmacol, 12, 638646
PubMed 34163352 DOI 10.3389/fphar.2021.638646
Mathiesen SB, Lunde M, Stensland M, Martinsen M, Nyman TA, Christensen G, Carlson CR (2020)
The Cardiac Syndecan-2 Interactome
Front Cell Dev Biol, 8, 792
PubMed 32984315 DOI 10.3389/fcell.2020.00792
view all >